Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Find out where to locate no annual fee credit cards that provide rewards. Maximize your earning potential today!
19,160 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
New York’s Democratic primaries produced surprising wins for a progressive slate, with Gaza policy shaping fundraisin...
Investors dig into a mixed session as Amazon leads gains on Prime Day momentum and AI shopping activity. This guide b...
Bitcoin led a broad sell-off, triggering over $600m liquidated hour across major contracts. ETH and XRP followed, as ...
Wendy's has surged about 40% over the past week, attracting intense options activity and renewed bets on a turnaround...
As of Jun 26, 2026, major tokens face renewed pressure with ETH and XRP testing critical supports while ADA and BNB s...
The AI hardware boom is fading as demand cools, dragging optical and memory stocks lower and prompting investors to r...
SpaceX began trading with high expectations and big swings. This article breaks down the moves from $135 to $154, exp...
PayPal has fallen from its peak, trading at low earnings multiples. Is this a genuine value play or a trap? This guid...
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
Meta Platforms has shown business momentum even as its stock traded lower. This guide weighs the case to buy, sell, o...
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...